Immunogenicity and Safety Study of Allantoic Split Inactivated Seasonal Influenza Vaccine (VSI)

NCT03016143 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

300

Enrollment

OTHER_GOV

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Allantoic Split Inactivated Seasonal flu Vaccine
BIOLOGICAL: VAXIGRIP

Sponsor

Research Institute for Biological Safety Problems

Collaborators

[object Object]
[object Object]